OP07: The epidemiology of Inflammatory Bowel Diseases among immigrants to Denmark: a population-based cohort studyECCO'20 Vienna 2020
1
OP08: Inflammatory Bowel Disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and SwedenECCO'20 Vienna 2020
1
OP09: Immunomodulatory mechanisms of faecal microbiota transplantation is associated with clinical response in Ulcerative Colitis – early results from STOP-ColitisECCO'20 Vienna 2020
1
OP10: IgA coating of intestinal microbiota is associated with Inflammatory Bowel Disease in twin pairs discordant for Inflammatory Bowel DiseaseECCO'20 Vienna 2020
1
OP12: The incidence and disease course of Perianal Crohn’s Disease - A Danish nationwide cohort studyECCO'20 Vienna 2020
1
OP14: Risk of colorectal cancer diagnosis and colorectal cancer mortality in Crohn’s Disease: A Scandinavian population-based cohort studyECCO'20 Vienna 2020
1
OP15: Multi-omic data integration with network analysis reveal underlying molecular mechanisms driving Crohn’s Disease heterogeneityECCO'20 Vienna 2020
1
OP17: Protein intakes and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD).ECCO'20 Vienna 2020
1
OP18: Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn's Disease: The SuPREMe-CD StudyECCO'20 Vienna 2020
1
OP19: Perinatal factors do not affect paediatric Inflammatory Bowel Disease risk: A Scottish nationwide cohort study using administrative health data 1981-2017ECCO'20 Vienna 2020
1
OP23: Efficacy and safety of vedolizumab SC in patients with Moderately to Severely active Crohn’s Disease: Results of the VISIBLE 2 studyECCO'20 Vienna 2020
1
OP27: Long-term safety and efficacy of risankizumab treatment in patients with Crohn’s Disease: Final results from the Phase 2 open-label extension studyECCO'20 Vienna 2020
1
OP28: Gene expression (GE) values in a phase 2 trial of mirikizumab in Ulcerative Colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scoresECCO'20 Vienna 2020
1
OP29: Tofacitinib in Ulcerative Colitis: Real world evidence from Eneida RegistryECCO'20 Vienna 2020
1